Martínez-Piñeiro Ja

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Guidelines on Urolithiasis<footref rid="foot01">¹</footref>

Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with Radiotherapy

Current perspectives in muscle invasive bladder cancer

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations

Bladder cancer

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer

Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer

Successful treatment of anabolic steroid–induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin

A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA

Ureteronephroscopic Endopyelotomy

Extracorporeal lithotripsy and combined surgical procedures in the treatment of renoureteral stone disease: Our experience with 2,955 patients

Karnofsky performance status revisited: reliability, validity, and guidelines.

The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer

Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

Bladder Cancer

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis

Mechanisms of Cisplatin Nephrotoxicity

Ureteroscopy: Current Practice and Long-Term Complications

Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III Study

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy

Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis

Current Surgical Approaches to Nephrolithiasis

Laparoscopic Dismembered Pyeloplasty

The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil.

Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO.

Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study.

[Review of complications of urinary diversions performed during a 6-year period in the era of orthotopic neobladders].

[Transurethral ureteroscopy. A current urological procedure].

[Klinefelter syndrome with hypogonadotropic hypogonadism and absence of Leydig cells].

Is chemotherapy a new form of radical treatment in infiltrating tumor localized to the bladder?